Document is current
Any future updates will be listed below
-
Authors
Kamal, Mona
Wang, Xin Shelley
Shi, Qiuling
Zyczynski, Teresa M.
Davis, Catherine
Williams, Loretta A.
Lin, Hui-Kai
Garcia-Gonzalez, Araceli
Cleeland, Charles S.
Orlowski, Robert
-
Funding
Funding for this research was provided by:
National Institutes of Health (P30CA016672)
Bristol-Myers Squibb (Bristol-Myers Squibb)
- License Information
-
More Information
Article History
Received: 17 December 2019
Accepted: 20 April 2020
First Online: 11 May 2020
Compliance with ethical standards
:
: Teresa M. Zyczynski and Catherine Davis are employees of Bristol-Myers Squibb. The MD Anderson Symptom Inventory (MDASI) and its modules are copyrighted and licensed by The University of Texas MD Anderson Cancer Center and Charles S. Cleeland. Charles Cleeland and Xin Shelley Wang have a financial interest in the MDASI and its modules. The authors have no other financial conflict of interest to disclose. The other authors declare that they have no conflict of interest.
: Informed consent was obtained from all individual participants included in the study.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional review committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
